Cimzia

Cimzia works by inhibiting tumor necrosis factor-alpha for those with plaque psoriasis. TNF-alpha is a cytokine, or protein, involved in systemic inflammation.

What is Cimzia?

Cimzia (also known by its generic name certolizumab pegol) is a biologic medication approved in September 2013 by the FDA for the treatment of active psoriatic arthritis and in May 2018 for the treatment of moderate-to-severe psoriasis in adults. It is also approved for treating rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.

Cimzia is given by injection under the skin. For patients with psoriatic arthritis, Cimzia is given at week 0 (the first week of treatment) and week 4, and then every every other week afterwards. maintenance dosing every 4 weeks can be considered. For patients with psoriasis, Cimzia is given at week 0 and then every other week. For some patients with psoriasis, a dose at weeks 0, 2, and 4, followed by every other week may be considered.

To learn more, please visit the Cimzia website.

FDA Approve stamp

FDA Approves Cimzia for Plaque Psoriasis

Clinical trial data show drug may help you achieve clear skin.

Read more
Illustrated graphic of people around a rocket ship and computer.

Advance Online

Get the latest news on new treatment options from NPF.

Stay up to date

Learn More About Your Treatment Options

The Patient Navigation Center is here to provide personalized information about your psoriasis and psoriatic arthritis treatment.

Contact a Patient Navigator today

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2020 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.